Clinical Study

Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience

Table 3

Reasons for discontinuation of previous biologic therapy.

First biologic drug used
  Primary failure5
  Secondary failure2
  Toxicity3
Second biologic drug used
  Primary failure3
  Secondary failure4
  Toxicity0
Third biologic drug used
  Primary failure2
  Secondary failure1
  Toxicity0
Fourth biologic drug used
  Primary failure1
  Secondary failure0
  Toxicity0